← Eichor
Study identifier: NCT05275881 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Virtual Reality in Hematology and Oncology During Invasive Procedures in Children, Adolescents and Young Adults, from 7 to Less Than 25 Years Old

Condition: Virtual Reality · Pediatrics · Cancer  ·  Sponsor: Poitiers University Hospital

PhaseNA
Planned participants60
Who can joinAll sexes, 7 Years to 24 Years
Healthy volunteersNo

About this study

This pilot study will be testing the feasibility of medical hypnosis through virtual reality during invasive médical procédures in children and young adults with cancer. Patients age from 7 to under 25 years whose treatement protocols required a lumbure puncture and a chemotherapy by implantable venous access will be randomly assigned to virtual reality or treatement as usual (nitrous oxide, anxiolytics, opioid analgesics, psychotropic and benzodiazepine). We expect the same benefit by using VR as usual intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Amandine AF FERNANDES  ·  +33549444578  ·  amandine.fernandes@chu-poitiers.fr

Karine KG ESTEVE-GARNIER  ·  +33549443567  ·  karine.garnier@chu-poitiers.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU poitiersPoitiers, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05275881